Back to Search Start Over

Microscale High-Throughput Experimentation as an Enabling Technology in Drug Discovery: Application in the Discovery of (Piperidinyl)pyridinyl-1H-benzimidazole Diacylglycerol Acyltransferase 1 Inhibitors.

Authors :
Cernak T
Gesmundo NJ
Dykstra K
Yu Y
Wu Z
Shi ZC
Vachal P
Sperbeck D
He S
Murphy BA
Sonatore L
Williams S
Madeira M
Verras A
Reiter M
Lee CH
Cuff J
Sherer EC
Kuethe J
Goble S
Perrotto N
Pinto S
Shen DM
Nargund R
Balkovec J
DeVita RJ
Dreher SD
Source :
Journal of medicinal chemistry [J Med Chem] 2017 May 11; Vol. 60 (9), pp. 3594-3605. Date of Electronic Publication: 2017 Mar 02.
Publication Year :
2017

Abstract

Miniaturization and parallel processing play an important role in the evolution of many technologies. We demonstrate the application of miniaturized high-throughput experimentation methods to resolve synthetic chemistry challenges on the frontlines of a lead optimization effort to develop diacylglycerol acyltransferase (DGAT1) inhibitors. Reactions were performed on ∼1 mg scale using glass microvials providing a miniaturized high-throughput experimentation capability that was used to study a challenging S <subscript>N</subscript> Ar reaction. The availability of robust synthetic chemistry conditions discovered in these miniaturized investigations enabled the development of structure-activity relationships that ultimately led to the discovery of soluble, selective, and potent inhibitors of DGAT1.

Details

Language :
English
ISSN :
1520-4804
Volume :
60
Issue :
9
Database :
MEDLINE
Journal :
Journal of medicinal chemistry
Publication Type :
Academic Journal
Accession number :
28252959
Full Text :
https://doi.org/10.1021/acs.jmedchem.6b01543